📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter? (2023)

First Author: Owens L

Attributed to: Evaluating new healthcare technologies in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1055-9965.epi-22-1307

PubMed Identifier: 37259797

Publication URI: http://europepmc.org/abstract/MED/37259797

Type: Journal Article/Review

Volume: 32

Parent Publication: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Issue: 6

ISSN: 1055-9965